Bernard Ravina

Bernard Ravina

UNVERIFIED PROFILE

Are you Bernard Ravina?   Register this Author

Register author
Bernard Ravina

Bernard Ravina

Publications by authors named "Bernard Ravina"

Are you Bernard Ravina?   Register this Author

75Publications

1414Reads

14Profile Views

Measuring peripheral nerve involvement in Friedreich's ataxia.

Ann Clin Transl Neurol 2019 Sep 15;6(9):1718-1727. Epub 2019 Aug 15.

Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.50865DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764626PMC
September 2019

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.

Neurol Genet 2019 Aug 9;5(4):e348. Epub 2019 Jul 9.

Laboratory of Neurogenetics (H.I., C.B., H.L.L., F.F., D.G.H., A.B.S., M.A.N.), National Institute on Aging, National Institutes of Health, Bethesda; Data Tecnica International (H.I., M.A.N.), Glen Echo, MD; Precision Neurology Program (G.L., C.R.S.), Harvard Medical School, Brigham and Women's Hospital; Neurogenomics Laboratory (G.L., C.R.S.), Harvard Medical School, Brigham and Women's Hospital; Ann Romney Center for Neurologic Diseases (G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; The Norwegian Centre for Movement Disorders (J.M.-G., G.A.), Stavanger University Hospital; Department of Chemistry (J.M.-G., G.A.), Bioscience and Environmental Engineering, University of Stavanger, Norway; Assistance-Publique Hôpitaux de Paris (J.-C.C.), ICM, INSERM UMRS 1127, CNRS 7225, ICM, Department of Neurology and CIC Neurosciences, Pitié-Salpêtrière Hospital, Paris, France; Department of Neurology (L.P., M.T.), Oslo University Hospital, Norway; Department of Neurology (M.N., B.R.B., B.P.W.), Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands; Michael J Fox Foundation (S.J.H.), New York; Translational Genome Sciences (K.-D.H.N, K.E.), Biogen, Cambridge, MA; Department of Neurology University of Pennsylvania (J.R.), Philadelphia, PA; Department of Biostatistics and Computational Biology (S.E.), University of Rochester, NY; Department of Computer Science (F.F.), University of Illinois Urbana-Champaign; Department of Neurology (P.A.), Center for Health + Technology, University of Rochester, NY; Department of Clinical Neurosciences (K.M.S., R.W.), University of Cambridge, John van Geest Centre for Brain Repair, UK; Department of Pathology and Laboratory Medicine (V.M.V.D.), Center for Neurodegenerative Disease Research, Parelman School of Medicine at the University of Pennsylvania, Philadelphia; Genetics and Pharmacogenomics (A.G.D.-W.), Merck Research Laboratory, Boston, MA; Statistical Genetics (A.G.D.-W.), Biogen, Cambridge, MA; Institut du cerveau et de la moelle épinière ICM (A.B., F.D.); Sorbonne Université SU (A.B.); INSERM UMR (A.B.), Paris, France; Department of Neurology (G.A.), Stavanger University Hospital, Norway; Preventive Neurology Unit (A.J.N.), Wolfson Institute of Preventive Medicine, Queen Mary University of London; Department of Molecular Neuroscience (A.J.N.), UCL Institute of Neurology, London, UK; Department of Neurology (O.-B.T.), Haukeland University Hospital; University of Bergen (O.-B.T.), Bergen, Norway; Department of Neurology (J.R.E.), Nottingham University NHS Trust, UK; Centre for Clinical Brain Sciences (D.P.B.), University of Edinburgh; Anne Rowling Regenerative Neurology Clinic (D.P.B.), University of Edinburgh; Usher Institute of Population Health Sciences and Informatics (D.P.B.), University of Edinburgh, Scotland; Department of Medical and Molecular Genetics (C.E.W.), Indiana University, Indianapolis; Department of Neurology (D.K.S.), Beth Israel Deaconess Medical Center; Harvard Medical School (D.K.S.), Boston; Voyager Therapeutics (B.R.), Cambridge, MA; Department of Neurology (B.R.), University of Rochester School of Medicine, NY; Institute of Clinical Medicine (M.T.), University of Oslo, Norway; German Center for Neurodegenerative Diseases-Tubingen (P.H.); HIH Tuebingen (P.H.), Germany; Department of Psychiatry (D.W.), University of Pennsylvania School of Medicine; Department of Veterans Affairs (D.W.), Philadelphia, PA; and Department of Clinical Neurosciences (R.A.B., C.H.W.-G.), University of Cambridge, UK; Department of Neurology (J.J.V.H.), Leiden University Medical Center, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXG.0000000000000348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659137PMC
August 2019

Gene therapy for neurological disorders: progress and prospects.

Nat Rev Drug Discov 2018 09 10;17(9):641-659. Epub 2018 Aug 10.

Voyager Therapeutics, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nrd.2018.110
Publisher Site
http://dx.doi.org/10.1038/nrd.2018.110DOI Listing
September 2018

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials.

Mov Disord 2018 04;33(4):528-536

Voyager Therapeutics, Cambridge, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27355DOI Listing
April 2018

Improved stratification of ALS clinical trials using predicted survival.

Ann Clin Transl Neurol 2018 Apr 9;5(4):474-485. Epub 2018 Mar 9.

Voyager Therapeutics, Inc. Cambridge Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.550DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899911PMC
April 2018

Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.

Lancet Neurol 2017 08 16;16(8):620-629. Epub 2017 Jun 16.

Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(17)30122-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761650PMC
August 2017

Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.

Brain 2015 Sep 28;138(Pt 9):2659-71. Epub 2015 Jul 28.

1 Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Cambridge, MA 02139, USA 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA 5 Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA 02115, USA 7 Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awv202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643625PMC
September 2015

Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.

Mov Disord 2014 Dec 4;29(14):1802-8. Epub 2014 Oct 4.

Center for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26051DOI Listing
December 2014

A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study.

Mov Disord 2014 May 11;29(6):743-9. Epub 2014 Feb 11.

Clinical Research, The Parkinson's Institute, Sunnyvale, California, USA; Department of Health Research and Policy, Stanford University, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25814DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656448PMC
May 2014

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Authors:
M Flint Beal David Oakes Ira Shoulson Claire Henchcliffe Wendy R Galpern Richard Haas Jorge L Juncos John G Nutt Tiffini Smith Voss Bernard Ravina Clifford M Shults Karen Helles Victoria Snively Mark F Lew Brian Griebner Arthur Watts Shan Gao Emmanuelle Pourcher Louisette Bond Katie Kompoliti Pinky Agarwal Cherissa Sia Mandar Jog Linda Cole Munira Sultana Roger Kurlan Irene Richard Cheryl Deeley Cheryl H Waters Angel Figueroa Ani Arkun Matthew Brodsky William G Ondo Christine B Hunter Joohi Jimenez-Shahed Alicia Palao Janis M Miyasaki Julie So James Tetrud Liza Reys Katharine Smith Carlos Singer Anita Blenke David S Russell Candace Cotto Joseph H Friedman Margaret Lannon Lin Zhang Edward Drasby Rajeev Kumar Thyagarajan Subramanian Donna Stuppy Ford David A Grimes Diane Cote Jennifer Conway Andrew D Siderowf Marian Leslie Evatt Barbara Sommerfeld Abraham N Lieberman Michael S Okun Ramon L Rodriguez Stacy Merritt Camille Louise Swartz W R Wayne Martin Pamela King Natividad Stover Stephanie Guthrie Ray L Watts Anwar Ahmed Hubert H Fernandez Adrienna Winters Zoltan Mari Ted M Dawson Becky Dunlop Andrew S Feigin Barbara Shannon Melissa Jill Nirenberg Mattson Ogg Samuel A Ellias Cathi-Ann Thomas Karen Frei Ivan Bodis-Wollner Sofya Glazman Thomas Mayer Robert A Hauser Rajesh Pahwa April Langhammer Ranjit Ranawaya Lorelei Derwent Kapil D Sethi Buff Farrow Rajan Prakash Irene Litvan Annette Robinson Alok Sahay Maureen Gartner Vanessa K Hinson Samuel Markind Melisa Pelikan Joel S Perlmutter Johanna Hartlein Eric Molho Sharon Evans Charles H Adler Amy Duffy Marlene Lind Lawrence Elmer Kathy Davis Julia Spears Stephanie Wilson Maureen A Leehey Neal Hermanowicz Shari Niswonger Holly A Shill Sanja Obradov Alex Rajput Marilyn Cowper Stephanie Lessig David Song Deborah Fontaine Cindy Zadikoff Karen Williams Karen A Blindauer Jo Bergholte Clara Schindler Propsom Mark A Stacy Joanne Field Dragos Mihaila Mark Chilton Ergun Y Uc Jeri Sieren David K Simon Lauren Kraics Althea Silver James T Boyd Robert W Hamill Christopher Ingvoldstad Jennifer Young Karen Thomas Sandra K Kostyk Joanne Wojcieszek Ronald F Pfeiffer Michel Panisset Monica Beland Stephen G Reich Michelle Cines Nancy Zappala Jean Rivest Richard Zweig L Pepper Lumina Colette Lynn Hilliard Stephen Grill Marye Kellermann Paul Tuite Susan Rolandelli Un Jung Kang Joan Young Jayaraman Rao Maureen M Cook Lawrence Severt Karyn Boyar

JAMA Neurol 2014 May;71(5):543-52

Department of Neurology, Beth Israel Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.131DOI Listing
May 2014

Cognition in movement disorders: where can we hope to be in ten years?

Mov Disord 2014 Apr;29(5):704-11

Institute for Aging and Health, Newcastle University, Newcastle upon Tyne, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25850DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371593PMC
April 2014

Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.

Mov Disord 2013 Dec 9;28(14):1980-6. Epub 2013 Oct 9.

Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25671DOI Listing
December 2013

Reply: Unusual DAT scan results.

Mov Disord 2013 Jun 4;28(6):847. Epub 2013 Apr 4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25447DOI Listing
June 2013

Performance of a shortened Scale for Assessment of Positive Symptoms for Parkinson's disease psychosis.

Parkinsonism Relat Disord 2013 Mar 1;19(3):295-9. Epub 2012 Dec 1.

University of Virginia, Department of Neurology, PO Box 800394, Charlottesville, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2012.10.022DOI Listing
March 2013

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

PLoS One 2012 27;7(8):e43595. Epub 2012 Aug 27.

The Cellular and Molecular Pharmacology Department, Rosalind Franklin University of Medicine and Science, The Chicago Medical School, North Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0043595PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428307PMC
February 2013

Many roads lead to Parkinson's disease.

Mov Disord 2013 Feb 24;28(2):122-3. Epub 2013 Jan 24.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25325DOI Listing
February 2013

Mortality in Friedreich ataxia.

J Neurol Sci 2011 Aug 8;307(1-2):46-9. Epub 2011 Jun 8.

Department of Neurology, University of Pennsylvania Medical School, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022510X110028
Publisher Site
http://dx.doi.org/10.1016/j.jns.2011.05.023DOI Listing
August 2011

Risk of surgical delivery to deep nuclei: a meta-analysis.

Mov Disord 2011 Jul 14;26(8):1415-21. Epub 2011 May 14.

Biomedical Ethics Unit, Department of Social Studies of Medicine, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23770DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532377PMC
July 2011

Finances of the publishers of the most highly cited US medical journals.

J Med Libr Assoc 2011 Jul;99(3):255-8

The Johns Hopkins Hospital, Department of Neurology, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3163/1536-5050.99.3.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133891PMC
July 2011

Predictors of cognitive outcomes in early Parkinson disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Parkinsonism Relat Disord 2010 Sep 2;16(8):507-12. Epub 2010 Jul 2.

Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, 1020 Locust Street, 521 JAH, Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S135380201000133
Publisher Site
http://dx.doi.org/10.1016/j.parkreldis.2010.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930040PMC
September 2010

Biomarkers of PD progression: is CSF the answer?

Neurology 2010 Sep 25;75(12):1036-7. Epub 2010 Aug 25.

Division of Psychiatry, Stavanger University Hospital, Arm Hansen v 20, N-4005 Stavanger, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e3181f6f272DOI Listing
September 2010

Local institutional review board (IRB) review of a multicenter trial: local costs without local context.

Ann Neurol 2010 Feb;67(2):258-60

Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ana.21831
Publisher Site
http://dx.doi.org/10.1002/ana.21831DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848288PMC
February 2010

Long term understanding of study information in research participants with Parkinson's disease.

Parkinsonism Relat Disord 2010 Jan 5;16(1):60-3. Epub 2009 Jun 5.

University of Rochester, School of Medicine and Dentistry, Department of Neurology, Rochester, NY 14610, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2009.05.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817997PMC
January 2010

Launching invasive, first-in-human trials against Parkinson's disease: ethical considerations.

Mov Disord 2009 Oct;24(13):1893-901

Biomedical Ethics Unit, Department of Social Studies of Medicine, McGill University, 3647 Peel Street, Montreal, QB H3A 1X1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989599PMC
October 2009

The course of depressive symptoms in early Parkinson's disease.

Mov Disord 2009 Jul;24(9):1306-11

Department of Neurology, University of Rochester School of Medicine and Dentistry, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22572DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788307PMC
July 2009

Neuroprotection trials in Parkinson's disease: systematic review.

Mov Disord 2009 Apr;24(5):647-54

Department of Neurology, University of Texas Health Science Center, San Antonio, Texas 78229-3900, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22432DOI Listing
April 2009

Predictors of progression in patients with Friedreich ataxia.

Mov Disord 2008 Oct;23(14):2026-32

Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland 20892-3705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579318PMC
October 2008

The relationship between CAG repeat length and clinical progression in Huntington's disease.

Mov Disord 2008 Jul;23(9):1223-7

Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21988DOI Listing
July 2008

Neuroprotection in Parkinson's disease: myth or reality?

Curr Neurol Neurosci Rep 2008 Jul;8(4):304-9

Department of Neurology, University of Rochester School of Medicine and Dentistry, Movement and Inherited Neurological Disorders Unit, Rochester, NY 14620, USA.

View Article

Download full-text PDF

Source
July 2008

The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease.

Mov Disord 2008 May;23(7):1043-1046

Department of Neurology, University of Rochester, Rochester, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22017DOI Listing
May 2008

A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone).

J Clin Pharmacol 2007 Dec 9;47(12):1580-6. Epub 2007 Oct 9.

Department of Neurology, Clinical Trials Coordination Center, University of Rochester Medical Center, Rochester, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270007307571DOI Listing
December 2007

Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia.

Arch Neurol 2007 Jun;64(6):803-8

Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-3705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.64.6.803DOI Listing
June 2007

Why hasn't neuroprotection worked in Parkinson's disease?

Nat Clin Pract Neurol 2007 May;3(5):240-1

University of Rochester Medical Center, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpneuro0491DOI Listing
May 2007

Neuroprotection in Parkinson's disease: an elusive goal.

Semin Neurol 2007 Apr;27(2):106-12

Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14620, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2007-971168DOI Listing
April 2007

Biomarkers in Parkinson's disease.

Expert Rev Neurother 2006 Jun;6(6):823-31

University of Rochester Medical Center, 1351 Mt. Hope Avenue, Suite 223, Rochester, NY 14620, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737175.6.6.823DOI Listing
June 2006

Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials.

Clin Trials 2005 ;2(6):509-18

Dept of Biostatistics, Bioinformatics & Epidemiology, Medical University of South Carolina, 135 Cannon St. Suite 303, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1191/1740774505cn125oaDOI Listing
March 2006

Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group.

Mov Disord 2006 Feb;21(2):148-58

Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.20723DOI Listing
February 2006

Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease.

Ann Neurol 2006 Jan;59(1):174-7

Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 1, Room B3-10, I Center Drive, MSC-0135, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.20688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351078PMC
January 2006

A responsive outcome for Parkinson's disease neuroprotection futility studies.

Ann Neurol 2005 Feb;57(2):197-203

Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.20361DOI Listing
February 2005

Funding evidence: the National Institute of Neurological Disorders and Stroke Clinical Trials Program.

NeuroRx 2004 Jul;1(3):317-22

National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC534931PMC
http://dx.doi.org/10.1602/neurorx.1.3.317DOI Listing
July 2004

Exercise-induced dystonia as a preceding symptom of familial Parkinson's disease.

Mov Disord 2004 Feb;19(2):228-30

Parkinson's Unit, Division of Neurogenetics, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.10626DOI Listing
February 2004

Mutation at the SCA17 locus is not a common cause of parkinsonism.

Parkinsonism Relat Disord 2003 Aug;9(6):317-20

Molecular Genetics Section, National Institute on Aging, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
August 2003

Brain banking for neurodegenerative diseases.

Curr Opin Neurol 2003 Aug;16(4):459-63

National Institute of Neurological Disorders and Stroke, NIH, MD 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.wco.0000084222.82329.f2DOI Listing
August 2003

From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials.

Nat Neurosci 2002 Nov;5 Suppl:1027-9

Technology Development Program, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nn931DOI Listing
November 2002

Preference-based quality-of-life in patients with Parkinson's disease.

Neurology 2002 Jul;59(1):103-8

Departments of Neurology, University of Pennsylvania School of Medicine, Philadelphia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/wnl.59.1.103DOI Listing
July 2002

Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease.

Control Clin Trials 2002 Apr;23(2):111-26

Department of Clinical Epidemiology and Biostatistics, School of Medicine, University of Pennsylvania, 621 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104-6021, USA

View Article

Download full-text PDF

Source
April 2002